The Nation - News from May 2, 1986
- Share via
The Food and Drug Administration, citing unexpected and puzzling reactions to a newly approved pain reliever, said it is telling physicians to prescribe the drug “only with caution.” The FDA said it has received 16 reports of back and flank pain and decreased kidney function among patients taking the prescription pain reliever Suprol, which has been on the market for less than four months. All 16 recovered after discontinuing the drug.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
